Divoll M, Greenblatt D J
Psychopharmacology (Berl). 1981;75(4):380-2. doi: 10.1007/BF00435857.
The binding of diazepam (DZ) and its major metabolite desmethyldiazepam (DMDZ) to plasma protein was evaluated in a series of controlled in vitro studies using equilibrium dialysis. Free fraction (FF) of both drugs alone changed significantly with total plasma drug concentration, but the increased FF (reduction in binding) did not occur until concentrations considerably exceeded those encountered during typical therapeutic use. Increasing concentrations of one drug at a time tended to increase FF for the other, although the effects were, at most, of borderline significance. Simultaneously increasing concentrations of both drugs led to significantly increased FF for both. Thus, DZ and DMDZ appear to bind to the same site or sites on plasma albumin. Binding is concentration-independent within and considerably above the usual therapeutic range.
使用平衡透析法在一系列体外对照研究中评估了地西泮(DZ)及其主要代谢产物去甲基地西泮(DMDZ)与血浆蛋白的结合情况。单独使用这两种药物时,游离分数(FF)均随血浆药物总浓度显著变化,但直到浓度大幅超过典型治疗用药时的浓度,游离分数增加(结合减少)才会出现。一次增加一种药物的浓度往往会使另一种药物的游离分数增加,尽管这种影响最多只是临界显著。同时增加两种药物的浓度会导致两者的游离分数显著增加。因此,DZ和DMDZ似乎结合于血浆白蛋白上的相同位点。在通常治疗范围及以上,结合与浓度无关。